IRF7 and breast carcinoma: In a retrospective analysis of data from 855 samples from primary breast cancers, high expression of an IRF7 pathway gene signature was associated with reduced bone metastasis of breast cancer (HR 0.63, 95% CI 0.42–0.93; P = 0.021) but had no prognostic value in predicting metastasis to visceral organs44.